Ro5
The AI engine Fit Assessment
BetaRo5 leverages machine learning to enhance drug discovery, identify patterns, and expand therapeutic options, including drug repurposing efforts for COVID-19.
Blurb
Biotechnology
HQ Location
London (United Kingdom)
Founded
2018
Employees
11 - 50
Total funding raised
Not available
Funding Status
Acquired by Juvenescence, June 2025
Subspaces
- Drug Repurposing
In the race to end disease and suffering, Ro5 uses artificial intelligence to cut the time and cost of drug discovery and development pipelines . . . and analytical solutions for clinical trials. For more information: www.ro5.ai